TG Therapeutics TGTX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License | $3.61M+201% | $3.46M+313% | $2.39M+311% | $2.31M+165% | $1.2M-90.8% | |
| License Revenue | $3.61M+201% | —— | $2.39M+311% | $2.31M+165% | $1.2M+3,061% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does TG Therapeutics break its business down?
- TG Therapeutics (TGTX) reports revenue by product across 2 parts — License and License Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does TG Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in TG Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
